Insider · CIK 0001539788
Louis C. Lucido
Files at BICX (BioCorRx Inc.). First filing Oct 11, 2022, latest Jan 17, 2024.
In brief
Louis C. Lucido files SEC Form 4 as president, director and 10% owner at BICX (BioCorRx Inc.). Since Oct 11, 2022, Louis C. Lucido has reported 3 open-market buys worth $9,484 and 0 open-market sells worth $0, the latest filed on Jan 17, 2024.
A track record needs three past buys with six months of prices behind them; Louis C. Lucido has 1, so none is measured yet.
The newest scored trade: bought $2,188 of BICX on Jan 12, 2024, filed Jan 17, 2024, scored 33 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BICX: BioCorRx Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | BICXbuy BioCorRx Inc. | $2,188 3,126 shares | +1% | +4% from low-68% from high | |
| 36Weak | BICXbuy BioCorRx Inc. | $4,170 5,000 shares | +6% | 0% from low-84% from high | |
| 33Weak | BICXbuy BioCorRx Inc. | $3,126 1,590 shares | +2% | 0% from low-60% from high |
Transactions
Every row this insider has filed, 30 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 24, 2024 | BICX BioCorRx Inc. | JOther Common Stock, par value $0.001 | +460,477 | $0.00 | $0 | 1,083,293 | Jan 31, 2025 |
| Jul 31, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +32,092 | $0.00 | $0 | 1,115,385 | Jan 31, 2025 |
| Aug 30, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +55,559 | $0.00 | $0 | 1,170,944 | Jan 31, 2025 |
| Sep 30, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +52,085 | $0.00 | $0 | 1,223,029 | Jan 31, 2025 |
| Sep 30, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +15,625 | $0.00 | $0 | 1,238,654 | Jan 31, 2025 |
| Oct 14, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +1,105,218 | $0.00 | $0 | 2,343,872 | Jan 31, 2025 |
| Oct 31, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +55,556 | $0.00 | $0 | 2,399,428 | Jan 31, 2025 |
| Nov 29, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +55,494 | $0.00 | $0 | 2,454,922 | Jan 31, 2025 |
| Dec 31, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +43,860 | $0.00 | $0 | 2,498,782 | Jan 31, 2025 |
| Dec 31, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +13,158 | $0.00 | $0 | 2,511,940 | Jan 31, 2025 |
| Jun 28, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +10,204 | $0.00 | $0 | 588,800 | Jul 10, 2024 |
| Jun 28, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +34,016 | $0.00 | $0 | 622,816 | Jul 10, 2024 |
| May 31, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +22,831 | $0.00 | $0 | 578,596 | Jun 3, 2024 |
| Apr 30, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +21,552 | $0.00 | $0 | 555,765 | May 1, 2024 |
| Mar 28, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +5,566 | $0.00 | $0 | 515,660 | Apr 3, 2024 |
| Mar 28, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +18,553 | $0.00 | $0 | 534,213 | Apr 3, 2024 |
| Jan 31, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +18,269 | $0.00 | $0 | 493,202 | Mar 7, 2024 |
| Feb 29, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +16,892 | $0.00 | $0 | 510,094 | Mar 7, 2024 |
| Jan 12, 2024 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +3,000 | $0.70 | $2,100 | 474,807 | Jan 17, 2024 |
| Jan 16, 2024 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +126 | $0.70 | $88 | 474,933 | Jan 17, 2024 |
| Jan 2, 2024 | BICX BioCorRx Inc. | AGrant or award Common Stock, par value $0.001 | +6,173 | $0.00 | $0 | 471,807 | Jan 4, 2024 |
| Dec 12, 2022 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +1,000 | $0.79 | $790 | 85,425 | Dec 15, 2022 |
| Dec 12, 2022 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +1,000 | $0.98 | $980 | 86,425 | Dec 15, 2022 |
| Dec 12, 2022 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +1,000 | $0.80 | $800 | 87,425 | Dec 15, 2022 |
| Dec 12, 2022 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +2,000 | $0.80 | $1,600 | 89,425 | Dec 15, 2022 |
| Sep 6, 2022 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +10 | $2.10 | $21 | 82,845 | Oct 11, 2022 |
| Oct 5, 2022 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +1,000 | $2.02 | $2,020 | 83,845 | Oct 11, 2022 |
| Oct 6, 2022 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +360 | $1.90 | $684 | 84,205 | Oct 11, 2022 |
| Oct 6, 2022 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +120 | $1.90 | $228 | 84,325 | Oct 11, 2022 |
| Oct 6, 2022 | BICX BioCorRx Inc. | POpen-market purchase Common Stock, par value $0.001 | +100 | $1.73 | $173 | 84,425 | Oct 11, 2022 |
Questions about Louis C. Lucido
Answered from the filings on this page, as of the latest one.
Is Louis C. Lucido buying or selling?
Not in the last 12 months. Louis C. Lucido's latest open-market trade on SEC Form 4 was bought $2,188 of BICX on Jan 12, 2024.
How did Louis C. Lucido's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Louis C. Lucido has 1.
Where does Louis C. Lucido file Form 4?
Louis C. Lucido has filed Form 4 at BICX (BioCorRx Inc.) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.